LHCGR rs10734412: Understanding This Genetic Variant
The rs10734412 variant is an intronic genetic change located within the LHCGR gene. It is studied for its potential role in modulating how cells respond to luteinizing hormone and human chorionic gonadotropin during reproductive processes.
What each genotype means
Typical gonadotropin sensitivity
You carry two copies of the common A allele in LHCGR. Research indicates this genotype is associated with baseline sensitivity to luteinizing hormone and human chorionic gonadotropin signaling during ovarian follicle development. However, current evidence is limited, and this variant alone does not determine fertility outcomes.
Found in approximately 48% of individuals of European ancestry and roughly 67% of East Asian populations.
Altered gonadotropin response
You carry one copy of the G allele, which has been investigated for subtle regulatory effects on LHCGR signaling efficiency. Available studies suggest heterozygous individuals may experience modest differences in follicular responsiveness to LH and hCG stimulation. Because scientific evidence remains preliminary and limited, these statistical trends should not be used as clinical indicators.
Carried by approximately 43% of people of European ancestry and roughly 30% of East Asian populations.
Modulated gonadotropin signaling
You carry two copies of the minor G allele in an intronic region of the LHCGR gene. In limited observational research, homozygous carriers have shown differences in receptor-mediated LH and hCG signaling during folliculogenesis. These findings reflect small population-level associations and do not serve as a diagnostic marker for reproductive health.
Carried by roughly 9% to 10% of European ancestry individuals and about 3% to 4% of East Asian populations.
What is rs10734412?
The rs10734412 variant is a single nucleotide polymorphism (SNP) situated within the LHCGR gene. In genetics, an intronic variant refers to a change located in a non-coding region of the gene, known as an intron. While introns do not provide the direct instructions for building the protein itself, they often contain regulatory elements that act like switches, determining when, where, and how much of a protein is produced. Because rs10734412 is located in such a region, researchers investigate whether it influences the expression levels or the regulatory environment of the LHCGR gene. It is important to note that this variant is a marker, meaning it is a specific point in the DNA sequence that researchers track to understand genetic diversity and its potential influence on biological traits.
The Role of the LHCGR Gene
The LHCGR gene provides the essential instructions for creating the luteinizing hormone/choriogonadotropin receptor. This receptor protein is found on the surface of specific cells in the reproductive system, including the ovaries in females and the Leydig cells in the testes of males. By binding to luteinizing hormone (LH) and human chorionic gonadotropin (hCG), the receptor triggers signaling pathways that are vital for reproductive health. In females, this signaling is crucial for the maturation of follicles and the process of ovulation. In males, it is necessary for the production of testosterone. Because the receptor is so central to these processes, variations in the gene can have wide-ranging effects. While some rare mutations in this gene are linked to conditions like Leydig cell hypoplasia, common variants like rs10734412 are generally studied for their more subtle influence on hormone sensitivity.
Research and Evidence Strength
Current research into rs10734412 is categorized as having limited evidence regarding its clinical impact. While the variant is identified in genomic databases as a regulatory candidate, it has not been definitively linked to specific medical conditions or significant changes in reproductive outcomes in the general population. Most studies involving LHCGR variants focus on rare, high-impact mutations that cause clear clinical disorders. In contrast, common variants like rs10734412 are often explored in the context of complex traits, where many different genes and environmental factors interact to produce a result. Because the evidence is currently limited, it is not possible to use this variant to predict individual health outcomes or fertility status. Scientific understanding of how this specific intronic change affects the receptor's function remains an active area of investigation, and findings should be viewed as preliminary rather than diagnostic.
Population Frequency
Genetic variants are distributed differently across global populations, and rs10734412 is no exception. Data indicates that the minor allele frequency for this variant is approximately 0.31 in European populations and about 0.18 in East Asian ancestries. These frequencies suggest that the variant is relatively common, appearing in a significant portion of the population. Understanding these frequencies is important for researchers because it helps them determine if a variant is a rare mutation or a common polymorphism. When a variant is common, it is less likely to be the sole cause of a severe, rare disease and more likely to contribute to natural variation in human traits. Researchers use these population-level statistics to refine their models and ensure that genetic studies are representative of diverse groups.
What This Information Means for You
If you have encountered information about the rs10734412 variant, it is important to understand that this is a common genetic marker with limited evidence of clinical significance. You cannot use this information to diagnose a medical condition, predict fertility, or make decisions about medical treatments. Genetic variants often exist in a complex landscape where their effects are influenced by other genes, lifestyle, and environmental factors. If you have concerns about your reproductive health or hormone levels, the most appropriate step is to consult with a qualified healthcare provider or a reproductive endocrinologist. They can perform clinical assessments, such as hormone testing or physical exams, which provide actionable medical information. Never use genetic data from public databases to alter your health management or medication regimen without direct guidance from your clinician.
How common is this variant?
The minor allele frequency for rs10734412 is approximately 0.31 in European populations and 0.18 in East Asian ancestries.
Frequently asked questions
Is rs10734412 associated with infertility?
There is currently no strong evidence linking the rs10734412 variant to infertility. While the LHCGR gene is vital for reproduction, this specific variant is considered a common regulatory marker rather than a known cause of reproductive disorders.
Can I use this variant to predict my hormone levels?
No, you cannot use this variant to predict your hormone levels. Hormone levels are influenced by a wide variety of factors, including age, health status, and environmental influences, which a single genetic variant cannot account for.
Should I be worried if I have the GG genotype?
No, there is no reason for concern. The GG genotype is a common variation found in the general population and is not classified as a disease-causing mutation.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, you should discuss them with a genetic counselor or your primary healthcare provider. They can help you interpret the information in the context of your personal and family medical history.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10734412?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LHCGR
Polymorphism in the luteinizing hormone/choriogonadotropin receptor gene linked to variation in ovarian sensitivity to gonadotropins during assisted reproduction.
A missense polymorphism (N291S) in the luteinizing hormone/choriogonadotropin receptor gene that influences receptor signaling efficiency and sensitivity to exogenous gonadotropins in ovarian stimulation protocols.
Regulatory SNP in LHCGR associated with ovarian responsiveness.
Luteinizing hormone/choriogonadotropin receptor gene locus polymorphism linked to polycystic ovary syndrome susceptibility.
Intronic regulatory variant in LHCGR modulating luteinizing hormone and human chorionic gonadotropin signaling, linked to susceptibility to polycystic ovary syndrome (PCOS).
Activating missense mutation in LHCGR causing familial male-limited precocious puberty (testotoxicosis).